Literature DB >> 20655336

Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease.

Gaukhman Alexander1, Amanda Hanna, Vanida Serna, Linda Younkin, Steve Younkin, Christopher Janus.   

Abstract

Behavioural and psychological signs and symptoms of dementia encompass a wide range of neuropsychiatric disturbances which coincide with progressing cognitive decline in Alzheimer's disease (AD). Physical aggression and agitation, which occurs in 20-65% of AD patients, is physically and emotionally stressful, not only to patients but also to immediate family and caregivers. The exact mechanisms underlying the increased aggressive behaviour in AD has yet to be elucidated. We used a transgenic mouse model, denoted Tg2576, which over-expresses a mutated human amyloid precursor protein (APP) gene implicated in familial AD, to investigate aggressive behaviour of males at the stage of amyloid beta pathology preceding overt amyloid plaque deposition in the brain. The aggressive behaviour of transgenic and non-transgenic littermate males was evaluated in a standard resident-intruder test in which an isolated resident male responded aggressively toward an experimentally naïve intruder male of A/J strain. We showed that 7-month-old Tg2576 resident males demonstrated significantly higher and unchanged level of aggression towards intruder males during 3 consecutive encounters as compared to their non-transgenic littermate counterparts. These results validate further the Tg2576 mouse model of AD underscoring its usefulness in studying non-mnemonic changes in behaviour related to the disease.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20655336     DOI: 10.1016/j.bbr.2010.07.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  13 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 2.  Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Authors:  Celina S Liu; Sarah A Chau; Myuri Ruthirakuhan; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 3.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

4.  Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult.

Authors:  Shaefali P Rodgers; Heather A Born; Pritam Das; Joanna L Jankowsky
Journal:  Mol Neurodegener       Date:  2012-06-18       Impact factor: 14.195

5.  Criminal manifestations of dementia patients: report from the national forensic hospital.

Authors:  Jeong-Min Kim; Kon Chu; Keun-Hwa Jung; Soon-Tae Lee; Sang-Sub Choi; Sang Kun Lee
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-12-24

Review 6.  Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models.

Authors:  Scott J Webster; Adam D Bachstetter; Peter T Nelson; Frederick A Schmitt; Linda J Van Eldik
Journal:  Front Genet       Date:  2014-04-23       Impact factor: 4.599

7.  Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.

Authors:  Louise Ørum Olesen; Elena V Bouzinova; Maurizio Severino; Mithula Sivasaravanaparan; Jørgen Bo Hasselstrøm; Bente Finsen; Ove Wiborg
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

Review 8.  The relationship between stress and Alzheimer's disease.

Authors:  Nicholas J Justice
Journal:  Neurobiol Stress       Date:  2018-04-21

9.  Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Rolf Daniels; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2013-09-05       Impact factor: 5.310

10.  Icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis.

Authors:  Zhi-Yuan Zhang; Chaoyun Li; Caroline Zug; Hermann J Schluesener
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.